文献速递心血管CT

冠状动脉钙化积分对TAVR术后全因死亡的增量预后价值

Incremental Prognostic Value of Coronary Artery Calcium Score for Predicting All-Cause Mortality after Transcatheter Aortic Valve Replacement.
PubMed 文献 · Radiology · 2021-08-03

本研究为单中心前瞻性注册数据的二次分析,纳入309例TAVR术前接受非增强心电门控心脏CT且无血运重建史的患者。

要点

  • TAVR术前非增强心电门控CT测得的CAC评分≥1000提示30天和1年死亡风险显著升高。
  • CAC评分可独立于EuroSCORE II预测TAVR术后30天和1年全因死亡。
  • CAC评分加入EuroSCORE II可改善1年死亡预测的区分度(C指数0.76 vs 0.69)。

核心结论

  • 在无既往冠状动脉血运重建史的患者中,CAC评分是TAVR术后30天和1年全因死亡的独立预测因子。
  • 将CAC评分加入EuroSCORE II可为TAVR术后1年死亡提供增量预后价值。

研究设计与样本

  • 单中心、机构审查委员会批准的二次分析,数据来自前瞻性收集的SwissTAVI Registry(ClinicalTrials.gov NCT01368250)。
  • 纳入2008年5月至2019年9月间TAVR术前接受包含非增强心电门控心脏扫描的CT、且无既往冠状动脉血运重建的参与者309例(平均年龄81岁±7,175例女性)。
  • 记录临床数据包括EuroSCORE II,测定CAC评分,采用Cox回归分析评估30天和1年全因死亡。

临床应用与阅片要点

  • TAVR术前非增强心电门控CT可同时评估CAC评分,CAC≥1000应提示临床关注术后30天和1年死亡风险。
  • CAC评分可作为EuroSCORE II之外的补充预后指标,用于TAVR术后风险分层。

局限性

  • 单中心研究。
  • 为前瞻性注册数据的二次分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Current risk models show limited performances for predicting all-cause mortality after transcatheter aortic valve replacement (TAVR). Purpose To determine the prognostic value of coronary artery calcium (CAC) scoring for predicting 30-day and 1-year mortality in patients undergoing TAVR. Materials and Methods In this single-center institutional review board-approved secondary analysis of prospectively collected data (SwissTAVI Registry), the authors evaluated participants who, before TAVR, underwent CT that included a nonenhanced electrocardiography-gated cardiac scan between May 2008 and September 2019 and who had not undergone previous coronary revascularization. Clinical data, including the European System for Cardiac Operative Risk Evaluation (EuroSCORE II), were recorded. The CAC score was determined, and 30-day and 1-year all-cause mortality were assessed by using Cox regression analyses. Results In total, 309 participants (mean age ± standard deviation, 81 years ± 7; 175 women) were included, with a median CAC score of 334 (interquartile range, 104-987). Seventy-seven of the 309 participants (25%) had a CAC score greater than or equal to 1000. A CAC score of 1000 or greater served as an independent predictor of 30-day (hazard ratio [HR], 4.5 [95% CI: 1.5, 13.6] compared with a CAC score <1000; P = .007) and 1-year (HR, 4.3 [95% CI: 1.5, 12.7] compared with a CAC score of 0-99; P = .008) mortality after TAVR. Similar trends were observed for each point increase of the EuroSCORE II as an independent predictor of 30-day (HR, 1.22 [95% CI: 1.10, 1.36]; P < .001) and 1-year (HR, 1.16 [95% CI: 1.08, 1.25]; P < .001) mortality. Adding the CAC score to the EuroSCORE II provided incremental prognostic value for 1-year mortality after TAVR over the EuroSCORE II alone (concordance index, 0.76 vs 0.69; P = .04). Conclusion In participants without prior coronary revascularization, the coronary artery calcium score represented an independent predictor of 30-day and 1-year mortality after transcatheter aortic valve replacement. ClinicalTrials.gov identifier, NCT01368250 © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Almeida in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Eberhard M, Hinzpeter R, Schönenberger ALN, et al. Incremental Prognostic Value of Coronary Artery Calcium Score for Predicting All-Cause Mortality after Transcatheter Aortic Valve Replacement. Radiology. 2021. PMID: 34342499. doi:10.1148/radiol.2021204623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。